Success Metrics

Clinical Success Rate
80.0%

Based on 20 completed trials

Completion Rate
80%(20/25)
Active Trials
0(0%)
Results Posted
15%(3 trials)
Terminated
5(17%)

Phase Distribution

Ph phase_1
14
47%
Ph not_applicable
3
10%
Ph early_phase_1
1
3%
Ph phase_2
11
37%
Ph phase_3
1
3%

Phase Distribution

15

Early Stage

11

Mid Stage

1

Late Stage

Phase Distribution30 total trials
Early Phase 1First-in-human
1(3.3%)
Phase 1Safety & dosage
14(46.7%)
Phase 2Efficacy & side effects
11(36.7%)
Phase 3Large-scale testing
1(3.3%)
N/ANon-phased studies
3(10.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

76.9%

20 of 26 finished

Non-Completion Rate

23.1%

6 ended early

Currently Active

0

trials recruiting

Total Trials

30

all time

Status Distribution
Completed(20)
Terminated(6)
Other(4)

Detailed Status

Completed20
Terminated5
unknown4
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
30
Active
0
Success Rate
80.0%
Most Advanced
Phase 3

Trials by Phase

Early Phase 11 (3.3%)
Phase 114 (46.7%)
Phase 211 (36.7%)
Phase 31 (3.3%)
N/A3 (10.0%)

Trials by Status

terminated517%
completed2067%
withdrawn13%
unknown413%

Recent Activity

0 active trials
Showing 5 of 30
unknownnot_applicable

Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy

NCT01082224
unknownnot_applicable

Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer

NCT01562223
completedphase_1

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

NCT00036790
completednot_applicable

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

NCT00003736
terminatedphase_1

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

NCT00089284
View all 30 trials

Clinical Trials (30)

Showing 20 of 30 trialsScroll for more
NCT01082224Not Applicable

Contrast-Enhanced CT and MRI in Diagnosing and Staging Liver Cancer Using UNOS Policy

Unknown
NCT01562223Not Applicable

Studying Repeated DCE-MRI and DWI in Patients Diagnosed With Prostate Cancer

Unknown
NCT00036790Phase 1

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Completed
NCT00003736Not Applicable

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

Completed
NCT00089284Phase 1

Phase I/II Trial of Redox Regulation in Patients With Relapsed or Refractory CD20+ NHL

Terminated
NCT00006452Phase 1

Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme

Completed
NCT00305864Phase 1

Motexafin Gadolinium, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Completed
NCT00387790Phase 2

Motexafin Gadolinium and Radiation Therapy in Treating Young Patients With Pontine Glioma

Completed
NCT00003411Phase 1

Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer

Completed
NCT00373204Phase 2

Study of the Effect on Non-small Cell Lung Cancer of the Investigational Drug Motexafin Gadolinium When Used in Combination With Docetaxel (Taxotere)

Terminated
NCT00076401Phase 2

A Study of Motexafin Gadolinium for the Treatment of Chronic Lymphocytic Leukemia (CLL)

Terminated
NCT00100711Phase 2

Study of Motexafin Gadolinium (MGd) in Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Terminated
NCT00121420Phase 2

Study of Motexafin Gadolinium With Whole Brain Radiation Therapy Followed by Stereotactic Radiosurgery Boost in the Treatment of Patients With Brain Metastases

Terminated
NCT00717587Phase 2

Sunitinib Before and After Surgery in Treating Patients With Stage IV Kidney Cancer

Unknown
NCT00514397Phase 2

Temozolomide and Radiation Therapy in Treating Young Patients With Pontine Glioma

Unknown
NCT00003410Phase 1

Motexafin Gadolinium With MRI-Guided Surgery in Treating Patients With High-Grade Gliomas

Completed
NCT00022256Phase 2

Motexafin Gadolinium Plus Radiation Therapy to the Brain in Treating Patients With Newly Diagnosed Glioblastoma Multiforme

Completed
NCT00005065Phase 1

Chemotherapy, Radiation Therapy, and Surgery in Treating Patients With Stage IIIA Non-small Cell Lung Cancer

Completed
NCT00004262Phase 1

Radiation Therapy and Gadolinium Texaphyrin in Treating Patients With Supratentorial Glioblastoma Multiforme

Completed
NCT00003909Phase 1

Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma

Completed

Drug Details

Intervention Type
DRUG
Total Trials
30